Genotype Resistance Testing

 Drug Resistance Testing in HIV-1 Infection - Genotype Assay
  By Daniel R. Kuritzkes, MD 

GENOTYPIC ASSAY: A test that determines if HIV has become resistant to the antiviral drug(s) the patient is currently taking. The test analyzes a sample of the virus from the patient's blood to identify any mutations in the virus that are associated with resistance to specific drugs. Also known as GART (Genotypic Antiretroviral Resistance Assay).

Articles on Genotypic Testing

Transmitted Drug Resistance Does Not Have a Long-term Impact on the Natural History of HIV infection or Response to First-line Therapy - 1/27/06

Should Genotypic Resistance Testing Be Performed for All Treatment-naive HIV Patients? - 10/07/05

Reduced Susceptibility to Protease Inhibitors (PI) in the Absence of Primary PI Resistance-associated Mutations - 6/15/05

Accuracy, Precision and Consistency of HIV-1 Genotype Interpretation by Experts - 6/13/05

Salvage Therapy Guided by Rules-based or Phenotype-driven HIV Genotypic Drug Resistance Interpretation with or without Concentration-controlled Intervention - 6/13/05

Drug Concentration Control Provides No Apparent Help in HIV Salvage Therapy - 6/08/05

Viral Rebound in Patients on First-line, PI-containing HAART Suggests a Lack of Adherence Rather Than the Selection of Resistant Variants - 4/04/05

 

 

 

 

 

 

 

 

 


 

HIV AND AIDS | HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH AND TECHNOLOGY | TESTS |
INTERNET CONFERENCE REPORTS | TELECONFERENCES | LINKS | ABOUT US | CONTACT US